Published date: Mar 25 2019

Journal Title: KnE Life Sciences

Issue title: The 1st International Conference on Health, Technology and Life Sciences (ICO-HELICS)

Pages: 282–287

DOI: 10.18502/kls.v4i12.4184

H Sulastomoherusulastomo@gmail.com

M D R D Ismaya

R Kusumawati

A A Nursidiq

There is a high prevalence of hypertension in elderly. Patients with long duration hypertension will suffer from vascular structure damage including brain vessel. Chronic disturbance in brain vascularization will lead to cognitive decline. This research aimed to assess the association between hypertension and cognitive decline in elderly. Sixty male elderly (60-75 years old) from posyandu lansia in Surakarta were involved in this research. They were divided into 2 groups, hypertensive and normotensive, each group consisted of 30 subjects. Subjects with a history of head injury, intracranial tumor, and cerebrovascular disease were excluded from this study. Hypertension status was obtained from the medical record. Hypertension level was based on Joint National Committee VII (JNC VII). Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA-INA). The mean age was 65.73±4.07 years old in the hypertensive group and 65.17±3.16 years old in normotensive group. There were significant differences in total MoCA-INA scores between hypertensive and normotensive (22±4.28 versus 24±5.56, p<0.01). Hypertension level had a negative correlation with total MoCA-INA score (r = - 0.318, p<0.01). We conclude that cognitive function in elderly with hypertension is lower than normotensive. Hypertension level has a strong correlation with cognitive decline in elderly.

[1] A Elias M F, Goodell A L and Dore G A 2012 Hypertension 60 260-8.


[2] Rizzoni D, De Ciuceis C, Porteri E, Paiardi S, Boari G E, Mortini P, Cornali C, Cenzato M, Rodella L F, Borsani E, Rizzardi N, Platto C, Rezzani R and Rosei E A 2009 J. Hypertens. 27 838-45


[3] Laurent S and Boutouyrie P 2015 Circ. Res.116 1007-21.


[4] Ritz K, Denswil N P, Stam O C, Van Lieshout J J and Daemen M J 2014 Circulation 130 1407–14.


[5] Tietz S and Engelhardt B 2015 J. Cell Biol. 209 493-506.


[6] Rosenberg G A 2012 J. Cereb. Blood Flow Metab. 32 1139-51.


[7] Huisa B N, Caprihan A, Thompson J, Prestopnik J, Qualls C R and Rosenberg G A 2015 Stroke 46 2413-18.


[8] Iadecola C 2013 Neuron 80 844-66.


[9] Pires P W, Dams Ramos C M, Matin N and Dorrance A M 2013 Am. J. Physiol. Heart Circ. Physiol. 304 H1598-H1614.


[10] Nagai M, Hoshide S, Ishikawa J, Shimada K and Kario K 2008 J. Hypertens. 26 1636- 41.


[11] Obisesan T O, Obisesan O A, Martins S, Alamgir L, Bond V, Maxwell C and Gillum RF 2008 J. Am. Geriatr. Soc. 56 501–9.


[12] Waldstein S R and Katzel L I 2005 Neurology 64 1746–9.


[13] Richmond R, Law J and Kay-Lambkin F 2011 Am. J. Hypertens. 24 299–303.


[14] Chobanian A V, et al. 2003 JAMA. 289 2560-72.


[15] Panentu D and Irfan M 2013 Jurnal fisioterapi. 13 55-67.


[16] Hobson J 2015 The montreal cognitive assesment (MoCA) Occup. Med. 65 764-5.


[17] Roalf D, Moberg P J, Xie S X, Wolk D A, Moelter S T and Arnold S E 2013 Alzheimers Dement. 9 529-27.


[18] Pelletier S, Nalpas B, Alarcon R, Rigole H and Perney P 2016 Journal of Addiction 1-7.


[19] Hewitt J, Williams M, Pearce L, Black A, Benson E, Tarrant M, Chakrabati M, Stechman M J, Moug S J and McCarthy K 2014 Int. J. Surg. 12 1031-5.


[20] Kuo H K, Sorond F, Iloputaife I, Gagnon M, Milberg W and Lipsitz L A 2004 J. Gerontol. 11 1191-4.


[21] Goldstein F C, Levey A I and Steenland N K 2013 J. Am. Geriatr. Soc. 61 67-73.


[22] Cerhan J R, Folsom A R, Mortimer J A, Shahar E, Knopman D S, McGovern P G, Hays M A, Crum L D and Heiss G 1998 Gerontology. 44 95-105.


[23] Dregan A, Stewart R and Gulliford M C 2013 Age Ageing 42 338-45.


[24] Elias P K, Elias M F, Robbins M A and Budge M M 2004 Hypertension. 44 631-36.


[25] Li Y, Shen Q, Huang S, Li W, Muir E R, Long J A and Duong T Q 2015 Cerebral angiography, blood flow and vascular reactivity in progressive hypertension. Neuroimage. 111 329-37.


[26] Moore S M, Zhang H, Maeda N, Doerschuk C M and Faber J E 2015 Angiogenesis 18 265-81.


[27] Price R S and Kasner S E 2014 Handb. Clin. Neurol. 119 161-7.


[28] Faraci F M 2011 Am. J. Physiol. Heart. Circ. Physiol. 300 H1566-82.


[29] Gąsecki D, Kwarciany M, Nyka W and Narkiewicz K 2013 Curr. Hypertens. Rep. 15 547–8.


[30] Lezak M 2004 Neuropsychological Assessment (New York: Oxford University Press) [31] Oveisgharan S and Hachinski V 2010 Arch. Neurol. 67 187-92.


[32] Gottesman R F, Schneider A L, Albert M, Alonso A, Bandeen-Roche K, Coker L, Coresh J, Knopman D, Power M C, Rawlings A, Sharrett A R, Wruck L M and Mosley T H 2014 JAMA. Neurol. 71 1218-27.


[33] Köhler S, Baars M A, Spauwen P, Schievink S, Verhey F R and Van Boxtel M J 2014 Hypertension 63 245-51.